Sign In
Buy MNMD
Mind Medicine (MindMed) . Subordinate Voting Shares Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -24.48. In total, the insiders bought 4.16M and sold 616.61K MNMD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-24.48 |
| ● Buy | 4.16M shares |
| ● Sell | 616.61K shares |
|
48% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Aug 20, 2024 Buy |
Barrow Robert Chief Executive Officer |
500 Value: $3K |
||
|
Aug 20, 2024 Buy |
Barrow Robert Chief Executive Officer |
500 Value: $3K |
||
|
Aug 19, 2024 Buy |
Barrow Robert Chief Executive Officer |
500 Value: $3K |
||
|
Aug 19, 2024 Buy |
Barrow Robert Chief Executive Officer |
500 Value: $3K |
||
|
Jun 25, 2024 Sell |
Karlin Dan Chief Medical Officer |
6 925 Value: $50.0K |
||
|
Jun 25, 2024 Sell |
Barrow Robert Chief Executive Officer |
15 659 Value: $113.1K |
||
|
Jun 25, 2024 Sell |
Sullivan Mark Chief Legal Officer |
17 854 Value: $128.9K |
||
|
Jun 25, 2024 Sell |
Sullivan Mark Chief Legal Officer |
17 854 Value: $128.9K |
||
|
Jun 25, 2024 Sell |
Barrow Robert Chief Executive Officer |
15 659 Value: $113.1K |
||
|
Jun 25, 2024 Sell |
Karlin Dan Chief Medical Officer |
6 925 Value: $50.0K |
||
|
Jun 10, 2024 Buy |
Vallone Carol A Director |
16 506 Value: $119.7K |
||
|
Jun 10, 2024 Buy |
Gryska David W Director |
16 506 Value: $119.7K |
||
|
Jun 10, 2024 Buy |
Crystal Roger Director |
16 506 Value: $119.7K |
||
|
Jun 10, 2024 Buy |
Bruhn Suzanne Louise Director |
16 506 Value: $119.7K |
||
|
Jun 10, 2024 Buy |
Krebs Andreas Director |
16 506 Value: $119.7K |
||
|
Jun 10, 2024 Buy |
Vallone Carol A Director |
16 506 Value: $119.7K |
||
|
Jun 10, 2024 Buy |
Gryska David W Director |
16 506 Value: $119.7K |
||
|
Jun 10, 2024 Buy |
Crystal Roger Director |
16 506 Value: $119.7K |
||
|
Jun 10, 2024 Buy |
Bruhn Suzanne Louise Director |
16 506 Value: $119.7K |
||
|
Jun 10, 2024 Buy |
Krebs Andreas Director |
16 506 Value: $119.7K |
||
|
Mar 25, 2024 Sell |
Greenway Schond L. Chief Financial Officer |
5 560 Value: $54.4K |
||
|
Mar 25, 2024 Sell |
Karlin Dan Chief Medical Officer |
6 578 Value: $62.5K |
||
|
Mar 25, 2024 Sell |
Barrow Robert Chief Executive Officer |
16 519 Value: $156.9K |
||
|
Mar 25, 2024 Sell |
Karlin Dan Chief Medical Officer |
6 578 Value: $62.5K |
||
|
Mar 25, 2024 Sell |
Greenway Schond L. Chief Financial Officer |
5 560 Value: $54.4K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
